Acrivon Therapeutics, Inc. (ACRV): DEFA14A filed May 22, 2026

Form type
DEFA14A
Filing date
May 22, 2026
Accession number
0001193125-26-236858
Filer
Acrivon Therapeutics, Inc. (CIK 1781174)